Luo Xingguang, Lin Xiandong, Ide Jaime S, Luo Xinqun, Zhang Yong, Xu Jianying, Wang Leilei, Chen Yu, Cheng Wenhong, Zheng Jianming, Wang Zhiren, Yu Ting, Taximaimaiti Reyisha, Jing Xiaozhong, Wang Xiaoping, Cao Yuping, Tan Yunlong, Li Chiang-Shan R
Beijing Huilongguan Hospital, Peking University Huilongguan Clinical School of Medicine, Beijing, 100096, China.
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
Child Adolesc Psychiatry Ment Health. 2023 Jan 6;17(1):4. doi: 10.1186/s13034-022-00536-0.
Attention deficit hyperactivity disorder (ADHD) is associated with reduction of cortical and subcortical gray matter volumes (GMVs). The kinectin 1 gene (KTN1) has recently been reported to significantly regulate GMVs and ADHD risk. In this study, we aimed to identify sex-specific, replicable risk KTN1 alleles for ADHD and to explore their regulatory effects on mRNA expression and cortical and subcortical GMVs. We examined a total of 1020 KTN1 SNPs in one discovery sample (ABCD cohort: 5573 males and 5082 females) and three independent replication European samples (Samples #1 and #2 each with 802/122 and 472/141 male/female offspring with ADHD; and Sample #3 with 14,154/4945 ADHD and 17,948/16,246 healthy males/females) to identify replicable associations within each sex. We examined the regulatory effects of ADHD-risk alleles on the KTN1 mRNA expression in two European brain cohorts (n = 348), total intracranial volume (TIV) in 46 European cohorts (n = 18,713) and the ABCD cohort, as well as the GMVs of seven subcortical structures in 50 European cohorts (n = 38,258) and of 118 cortical and subcortical regions in the ABCD cohort. We found that four KTN1 variants significantly regulated the risk of ADHD with the same direction of effect in males across discovery and replication samples (0.003 ≤ p ≤ 0.041), but none in females. All four ADHD-risk alleles significantly decreased KTN1 mRNA expression in all brain regions examined (1.2 × 10 ≤ p ≤ 0.039). The ADHD-risk alleles significantly increased basal ganglia (2.8 × 10 ≤ p ≤ 0.040) and hippocampus (p = 0.010) GMVs but reduced amygdala GMV (p = 0.030) and TIV (0.010 < p ≤ 0.013). The ADHD-risk alleles also significantly reduced some cortical (right superior temporal pole, right rectus) and cerebellar but increased other cortical (0.007 ≤ p ≤ 0.050) GMVs. To conclude, we identified a set of replicable and functional risk KTN1 alleles for ADHD, specifically in males. KTN1 may play a critical role in the pathogenesis of ADHD, and the reduction of specific cortical and subcortical, including amygdalar but not basal ganglia or hippocampal, GMVs may serve as a neural marker of the genetic effects.
注意缺陷多动障碍(ADHD)与皮质和皮质下灰质体积(GMV)减少有关。最近有报道称驱动蛋白1基因(KTN1)可显著调节GMV和ADHD风险。在本研究中,我们旨在识别ADHD的性别特异性、可重复的风险KTN1等位基因,并探讨它们对mRNA表达以及皮质和皮质下GMV的调节作用。我们在一个发现样本(ABCD队列:5573名男性和5082名女性)和三个独立的欧洲重复样本(样本1和样本2分别有802/122和472/141名患有ADHD的男性/女性后代;样本3有14154/4945名患有ADHD的男性/女性和17948/16246名健康男性/女性)中检测了总共1020个KTN1单核苷酸多态性(SNP),以识别每种性别内的可重复关联。我们在两个欧洲脑队列(n = 348)中研究了ADHD风险等位基因对KTN1 mRNA表达的调节作用,在46个欧洲队列(n = 18713)和ABCD队列中研究了对总颅内体积(TIV)的调节作用,以及在50个欧洲队列(n = 38258)中对七个皮质下结构的GMV和在ABCD队列中对118个皮质和皮质下区域的GMV的调节作用。我们发现,在发现和重复样本中,四个KTN1变体在男性中显著调节ADHD风险,且效应方向相同(0.003≤p≤0.041),但在女性中未发现。所有四个ADHD风险等位基因在所有检测的脑区中均显著降低KTN1 mRNA表达(1.2×10≤p≤0.039)。ADHD风险等位基因显著增加基底神经节(2.8×10≤p≤0.040)和海马体(p = 0.010)的GMV,但降低杏仁核GMV(p = 0.030)和TIV(0.010<p≤0.013)。ADHD风险等位基因还显著降低了一些皮质(右侧颞上极、右侧直肌)和小脑的GMV,但增加了其他皮质的GMV(0.007≤p≤0.050)。总之,我们识别出了一组ADHD的可重复且具有功能的风险KTN1等位基因,特别是在男性中。KTN1可能在ADHD的发病机制中起关键作用,特定皮质和皮质下GMV的减少,包括杏仁核而非基底神经节或海马体的GMV减少,可能作为遗传效应的神经标志物。